Evidence map›Paper›PMID 25162296›Full record

ArticlePloS one2014

Anti-metastasis effect of fucoidan from Undaria pinnatifida sporophylls in mouse hepatocarcinoma Hca-F cells.

Peisheng Wang, Zhichao Liu, Xianli Liu, Hongming Teng, Cuili Zhang, Lin Hou, Xiangyang Zou

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
10.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Fucoidan in cancer therapy: from biomedical application to medicinal chemistry approach.Journal of materials science. Materials in medicine · 2025
    Review
  4. Article
  5. A Sulfated Polysaccharide from Red Algae (Foods (Basel, Switzerland) · 2022
    Article
  6. Review
  7. Review
  8. Sulfated heteropolysaccharides fromFood chemistry: X · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Journal of applied phycology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Peisheng WangDepartment of Biotechnology, Dalian Medical University, Dalian, PR China.
Zhichao LiuDepartment of Biotechnology, Dalian Medical University, Dalian, PR China.
Xianli LiuDepartment of Biotechnology, Dalian Medical University, Dalian, PR China.
Hongming TengDepartment of Biotechnology, Dalian Medical University, Dalian, PR China.
Cuili ZhangDepartment of Biotechnology, Dalian Medical University, Dalian, PR China.
Lin HouCollege of Life Sciences, Liaoning Normal University, Dalian, PR China.
Xiangyang ZouDepartment of Biotechnology, Dalian Medical University, Dalian, PR China.
Dalian Medical University · CNLiaoning Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastasis is one of the major causes of cancer-related death. It is a complex biological process involving multiple genes, steps, and phases. It is also closely connected to many biological activities of cancer cells, such as growth, invasion, adhesion, hematogenous metastasis, and lymphatic metastasis. Fucoidan derived from Undaria pinnatifida sporophylls (Ups-fucoidan) is a sulfated polysaccharide with more biological activities than other fucoidans. However, there is no information on the effects of Ups-fucoidan on tumor invasion and metastasis. We used the mouse hepatocarcinoma Hca-F cell line, which has high invasive and lymphatic metastasis potential in vitro and in vivo, to examine the effect of Ups-fucoidan on cancer cell invasion and metastasis. Ups-fucoidan exerted a concentration- and time-dependent inhibitory effect on tumor metastasis in vivo and inhibited Hca-F cell growth, migration, invasion, and adhesion capabilities in vitro. Ups-fucoidan inhibited growth and metastasis by downregulating vascular endothelial growth factor (VEGF) C/VEGF receptor 3, hepatocyte growth factor/c-MET, cyclin D1, cyclin-dependent kinase 4, phosphorylated (p) phosphoinositide 3-kinase, p-Akt, p-extracellular signal regulated kinase (ERK) 1/2, and nuclear transcription factor-κB (NF-κB), and suppressed adhesion and invasion by downregulating L-Selectin, and upregulating protein levels of tissue inhibitor of metalloproteinases (TIMPs). The results suggest that Ups-fucoidan suppresses Hca-F cell growth, adhesion, invasion, and metastasis capabilities and that these functions are mediated through the mechanism involving inactivation of the NF-κB pathway mediated by PI3K/Akt and ERK signaling pathways.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsAntineoplastic Agents, PhytogenicCarcinoma, HepatocellularCell AdhesionCell Line, TumorCell MovementCell ProliferationCyclin D1Cyclin-Dependent Kinase 4Dose-Response Relationship, DrugHepatocyte Growth FactorLiver Neoplasms, ExperimentalLymphatic MetastasisMaleMAP Kinase Signaling SystemAntineoplastic Agents, PhytogenicCcnd1 protein, mouseCdk4 protein, mouseCyclin D1Cyclin-Dependent Kinase 4fucoidanHepatocyte Growth FactorNF-kappa BPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPlant ExtractsPolysaccharidesProto-Oncogene Proteins c-metReceptors, Vascular Endothelial Growth FactorVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouse

Identifiers

PMID25162296
PMCPMC4146566
OpenAlexW1992478508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.